Annual ROE
-2571.18%
-2190.98%-576.27%
December 31, 2024
Summary
- As of March 10, 2025, TELO annual return on equity is -2571.18%, with the most recent change of -2190.98% (-576.27%) on December 31, 2024.
- During the last 3 years, TELO annual ROE has fallen by -2671.18% (-2671.18%).
- TELO annual ROE is now -2671.18% below its all-time high of 100.00%, reached on December 1, 2021.
Performance
TELO ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-1170.71%
-82.80%-7.61%
December 31, 2024
Summary
- As of March 10, 2025, TELO quarterly return on equity is -1170.71%, with the most recent change of -82.80% (-7.61%) on December 31, 2024.
- Over the past year, TELO quarterly ROE has stayed the same.
- TELO quarterly ROE is now -961.58% below its all-time high of 135.88%, reached on March 1, 2023.
Performance
TELO Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
TELO ROE Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -576.3% | 0.0% |
3 y3 years | -2671.2% | 0.0% |
5 y5 years | -2671.2% | 0.0% |
TELO ROE Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -2671.2% | at low | -961.6% | at low |
5 y | 5-year | -2671.2% | at low | -961.6% | at low |
alltime | all time | -2671.2% | at low | -961.6% | at low |
Telomir Pharmaceuticals ROE History
Date | Annual | Quarterly |
---|---|---|
Dec 2024 | -2571.18%(+576.3%) | -1170.71%(+7.6%) |
Sep 2024 | - | -1087.91%(+48.0%) |
Jun 2024 | - | -734.95%(+22.1%) |
Mar 2024 | - | -601.92%(+45.9%) |
Dec 2023 | -380.20% | -412.55%(+66.7%) |
Date | Annual | Quarterly |
---|---|---|
Sep 2023 | - | -247.46%(+32.6%) |
Jun 2023 | - | -186.57%(-237.3%) |
Mar 2023 | - | 135.88%(+61.1%) |
Dec 2022 | 91.12%(-8.9%) | - |
Dec 2022 | - | 84.36% |
Dec 2021 | 100.00% | - |
FAQ
- What is Telomir Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Telomir Pharmaceuticals?
- What is Telomir Pharmaceuticals annual ROE year-on-year change?
- What is Telomir Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Telomir Pharmaceuticals?
- What is Telomir Pharmaceuticals quarterly ROE year-on-year change?
What is Telomir Pharmaceuticals annual return on equity?
The current annual ROE of TELO is -2571.18%
What is the all time high annual ROE for Telomir Pharmaceuticals?
Telomir Pharmaceuticals all-time high annual return on equity is 100.00%
What is Telomir Pharmaceuticals annual ROE year-on-year change?
Over the past year, TELO annual return on equity has changed by -2190.98% (-576.27%)
What is Telomir Pharmaceuticals quarterly return on equity?
The current quarterly ROE of TELO is -1170.71%
What is the all time high quarterly ROE for Telomir Pharmaceuticals?
Telomir Pharmaceuticals all-time high quarterly return on equity is 135.88%
What is Telomir Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, TELO quarterly return on equity has changed by 0.00% (0.00%)